Literature DB >> 16248655

Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: a chemical approach.

Victor E Marquez1, Yongseok Choi, Maria Julieta Comin, Pamela Russ, Clifford George, Mahmoud Huleihel, Tsipi Ben-Kasus, Riad Agbaria.   

Abstract

The herpes virus thymidine kinase (HSV-tk) is a critical enzyme for the activation of anti-HSV nucleosides. However, a successful therapeutic outcome depends not only on the activity of this enzyme but also on the ability of the compound(s) to interact effectively with cellular kinases and with the target viral or cellular DNA polymerases. Herein, we describe the synthesis and study of two nucleoside analogues built on a conformationally locked bicyclo[3.1.0]hexane template designed to investigate the conformational preferences of HSV-tk for the 2'-deoxyribose ring. Intimately associated with the conformation of the 2'-deoxyribose ring is the value of the C-N torsion angle chi, which positions the nucleobase into two different domains (syn or anti). The often-conflicting sugar and nucleobase conformational parameters were studied using North and South methanocarbadeoxythymidine analogues (6 and 7), which forced HSV-tk to make a clear choice in the conformation of the substrate. The results provide new insights into the mechanism of action of this enzyme, which cannot be gleaned from a static X-ray crystal structure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248655     DOI: 10.1021/ja053789s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.

Authors:  Kiran S Toti; Danielle Osborne; Antonella Ciancetta; Detlev Boison; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2016-07-13       Impact factor: 7.446

2.  D-(+)-iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase.

Authors:  Maria J Comin; B Christie Vu; Paul L Boyer; Chenzhong Liao; Stephen H Hughes; Victor E Marquez
Journal:  ChemMedChem       Date:  2008-07       Impact factor: 3.540

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.